Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUROCOVID: Persistence of SARS-CoV-2 in Olfactory Mucosa of Long COVID Patients
NCT05220241Completed
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Jul 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Adolphe de Rothschild Foundation Hospital. Primary endpoint: Presence of SARS-CoV-2 RNA in the olfactory mucosa. Started Jul 2022; status: completed.
Beyond the preview
Go deeper on NCT05220241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05220241.